Abraham Pinter

USPTO Granted Patents = 14 (Patent Applications = 5)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 4)

Average Co-Inventor Count = 1.6

ph-index = 6

Forward Citations = 159(Granted Patents)

Company Filing History:

5 out of 29

The Public Health Research Institute of the City of New York, Inc.

patents

5 out of 1,454

Rutgers, the State University of New Jersey

patents

1 out of 444

Research, Incorporated

patents

4. 1 out of 1,991

The State University of New York

University of Massachusetts

patents

8. 1 out of 269

University of Medicine and Dentistry of New Jersey

patents

where one patent can have more than one assignee

Years Active: 1983-2025

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12303562 - Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment ofinfections (2025-05-20),

2. 11707525 - Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment ofinfections (2023-07-25),

3. 11273220 - Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment ofinfections (2022-03-15),

4. 10729771 - Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment ofinfections (2020-08-04),

5. 9938325 - HIV-1 antigens with discrete conformational forms in the V1/V2 domain and methods of use thereof (2018-04-10),

6. 9796773 - Neutralizing antibodies that bind to the HIV-1 Env V2 critical neutralization domain (2017-10-24),

7. 8961987 - Immunogen comprising the HIV GP120 V3 loop in a conformation that induces broadly neutralizing antibodies (2015-02-24),

8. 8475799 - HIV-1 GP41 neutralization domain and use thereof (2013-07-02),

9. 6815201 - HIV-1 gp120 V1/V2 domain epitopes capable of generating neutralizing antibodies (2004-11-09),

10. 5952474 - Fusion glycoproteins (1999-09-14),

11. 5922325 - Synergistic neutralization of HIV-1 by human monoclonal antibodies and (1999-07-13),

12. 5643756 - Fusion glycoproteins (1997-07-01),

13. 5616459 - Selection of ribozymes that efficiently cleave target RNA (1997-04-01),

14. 4406885 - Preparation of native oncornavirus envelope subunits and vaccines (1983-09-27),

Title: The Innovations of Abraham Pinter

Introduction

Abraham Pinter is a notable inventor based in Brooklyn, NY, with a significant contribution to the field of medical research. He holds a total of 14 patents, showcasing his dedication to innovation and advancement in healthcare.

Latest Patents

Among his latest patents are the Anti-LAM and anti-PIM6/LAM monoclonal antibodies for the diagnosis and treatment of infections. These inventions provide various compositions, kits, vectors, and methods that include monoclonal antibodies directed to epitopes found within lipoarabinomannan (LAM) and phosphatidyl-myo-inositol mannoside 6 (PIM6). These advancements are crucial for improving diagnostic and therapeutic approaches to infections.

Career Highlights

Abraham Pinter has had a distinguished career, working with prominent institutions such as the Public Health Research Institute of the City of New York and Rutgers, the State University of New Jersey. His work has significantly impacted the field of public health and infectious disease research.

Collaborations

Throughout his career, Pinter has collaborated with esteemed colleagues, including Alok K Choudhary and Samuel Kayman. These partnerships have fostered innovation and contributed to the success of his research endeavors.

Conclusion

Abraham Pinter's contributions to medical research through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to influence the diagnosis and treatment of infections, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.